Iris C. Salaroglio

2.1k total citations
41 papers, 1.5k citations indexed

About

Iris C. Salaroglio is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Iris C. Salaroglio has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Iris C. Salaroglio's work include Nanoparticle-Based Drug Delivery (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). Iris C. Salaroglio is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). Iris C. Salaroglio collaborates with scholars based in Italy, Spain and Portugal. Iris C. Salaroglio's co-authors include Chiara Riganti, Joanna Kopecka, Elena Gazzano, Ana Bela Sarmento‐Ribeiro, Eleonora Mungo, Ilaria Buondonno, Simona Saponara, Menachem Rubinstein, Javier De Las Rivas and Elísabeth Pérez-Ruiz and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Iris C. Salaroglio

40 papers receiving 1.5k citations

Peers

Iris C. Salaroglio

ONCOL

BIOMA

Wantong Yao China

Zeng Fan China

Ganfeng Xie China

Yan Fan China

Melissa Millard United States

Kee-Ho Lee South Korea

Pengfei Shi China

Gaichao Zhao China

Yangbo Feng United States

Wantong Yao China

Iris C. Salaroglio

770 ×1.0

540 ×1.3

ONCOL

382 ×1.1

171 ×0.8

148 ×0.7

BIOMA

Citations per year, relative to Iris C. Salaroglio Iris C. Salaroglio (= 1×) peers Wantong Yao

Countries citing papers authored by Iris C. Salaroglio

Since Specialization

Citations

This map shows the geographic impact of Iris C. Salaroglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris C. Salaroglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris C. Salaroglio more than expected).

Fields of papers citing papers by Iris C. Salaroglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris C. Salaroglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris C. Salaroglio. The network helps show where Iris C. Salaroglio may publish in the future.

Co-authorship network of co-authors of Iris C. Salaroglio

This figure shows the co-authorship network connecting the top 25 collaborators of Iris C. Salaroglio. A scholar is included among the top collaborators of Iris C. Salaroglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris C. Salaroglio. Iris C. Salaroglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andreana, Ilaria, Caterina Ricci, Iris C. Salaroglio, et al.. (2024). Smart hyaluronated micelles to enhance a gemcitabine prodrug efficacy. Journal of Drug Delivery Science and Technology. 104. 106518–106518. 3 indexed citations

Godel, Martina, Simona Fontana, Muhlis Akman, et al.. (2024). Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro. Fluids and Barriers of the CNS. 21(1). 89–89. 9 indexed citations

Sapino, Simona, Elena Peira, Daniela Chirio, et al.. (2024). Human and canine osteosarcoma cell lines: How do they react upon incubation with calcium phosphate-coated lipid nanoparticles carrying doxorubicin and curcumin?. International Journal of Pharmaceutics. 668. 124970–124970.

Vecchia, Sofia La, Simona Fontana, Iris C. Salaroglio, et al.. (2024). Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy. Cancer Letters. 604. 217221–217221. 9 indexed citations

Bartkowski, Michał, Iris C. Salaroglio, Giacomo Ceccone, et al.. (2023). Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs. Journal of Colloid and Interface Science. 659. 339–354. 25 indexed citations

Hattinger, Claudia Maria, Iris C. Salaroglio, Martina Godel, et al.. (2023). Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences. 24(1). 799–799. 8 indexed citations

Salaroglio, Iris C., Fabrizio Tabbò, Sofia La Vecchia, et al.. (2023). Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer. Clinical Cancer Research. 29(19). 3958–3973. 17 indexed citations

Salaroglio, Iris C., Xavier Fontrodona, Isabel Romero, et al.. (2023). Fighting Multidrug Resistance with Ruthenium–Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition. Journal of Medicinal Chemistry. 66(20). 14080–14094. 4 indexed citations

Campani, Virginia, Iris C. Salaroglio, Valeria Nele, et al.. (2022). Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors. Pharmaceutics. 14(2). 292–292. 9 indexed citations

10.

Geddo, Federica, Susanna Antoniotti, Giulia Querio, et al.. (2021). Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation. Nutrients. 13(3). 916–916. 9 indexed citations

11.

Gonçalves, Ana Cristina, Joana Jorge, Cristina P. R. Xavier, et al.. (2021). Impact of cancer metabolism on therapy resistance – Clinical implications. Drug Resistance Updates. 59. 100797–100797. 98 indexed citations

12.

Kopecka, Joanna, Iris C. Salaroglio, Elísabeth Pérez-Ruiz, et al.. (2021). Hypoxia as a driver of resistance to immunotherapy. Drug Resistance Updates. 59. 100787–100787. 170 indexed citations

13.

Busacca, Sara, Qi Zhang, Annabel Sharkey, et al.. (2021). Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression. Scientific Reports. 11(1). 7434–7434. 5 indexed citations

14.

Akman, Muhlis, Dimas Carolina Belisario, Iris C. Salaroglio, et al.. (2021). Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. Journal of Experimental & Clinical Cancer Research. 40(1). 28–28. 117 indexed citations

15.

Salaroglio, Iris C., Carmen Abate, Barbara Rolando, et al.. (2019). Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain–Blood Barrier and Glioblastoma Stem Cells. Molecular Pharmaceutics. 16(8). 3361–3373. 21 indexed citations

16.

Salaroglio, Iris C., Prashant Mujumdar, Laura Annovazzi, et al.. (2018). Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein–Mediated Resistance to Temozolomide in Glioblastoma. Molecular Cancer Therapeutics. 17(12). 2598–2609. 36 indexed citations

17.

Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations

18.

Salaroglio, Iris C., Elisa Panada, Enrico Moiso, et al.. (2017). PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. Molecular Cancer. 16(1). 91–91. 157 indexed citations

19.

Buondonno, Ilaria, Elena Gazzano, Sae Rin Jean, et al.. (2016). Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma. Molecular Cancer Therapeutics. 15(11). 2640–2652. 83 indexed citations

20.

Riganti, Chiara, Iris C. Salaroglio, Valentina Caldera, et al.. (2013). Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway. Neuro-Oncology. 15(11). 1502–1517. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact